Core Viewpoint - The company, Aoke Co., Ltd. (300082), has indicated that its polyethylene glycol products are primarily used in pharmaceutical excipients, active pharmaceutical ingredients, lithium battery new energy, and daily chemical fields [1] Group 1 - The company's polyethylene glycol products are utilized in the pharmaceutical industry [1] - The products also serve as raw materials for active pharmaceutical ingredients [1] - The applications extend to the lithium battery new energy sector [1] Group 2 - The daily chemical industry is another key area where the company's products are applied [1]

Core Viewpoint - The company, Aoke Co., Ltd. (300082.SZ), has achieved EXCiPACT certification for its pharmaceutical-grade polyethylene glycol products and is currently serving over 400 pharmaceutical formulation enterprises, although its products do not yet cover the brain-machine interface field [1] Group 1 - The company has successfully obtained EXCiPACT certification for its entire range of pharmaceutical-grade polyethylene glycol [1] - The company is currently providing services to more than 400 pharmaceutical formulation enterprises [1] - The company indicates that if there are any developments in business expansion that meet disclosure standards, it will announce them in accordance with legal and regulatory requirements [1] Group 2 - The company emphasizes its commitment to continuous innovation and stable production capacity to serve its clients [1] - The company aims to promote the development of high-end application fields [1]

Core Viewpoint - The company has achieved EXCiPACT certification for its pharmaceutical-grade polyethylene glycol products and is currently serving over 400 pharmaceutical formulation enterprises, although its products do not yet extend to the brain-machine interface field [1] Group 1: Company Developments - The company has successfully passed EXCiPACT certification for its entire range of pharmaceutical-grade polyethylene glycol [1] - The company is currently providing services to more than 400 pharmaceutical formulation enterprises [1] - The company will disclose specific business expansion details in accordance with legal and regulatory standards if they meet the disclosure criteria [1] Group 2: Future Outlook - The company aims to continue leveraging innovative technologies and stable production capacity to serve its clients [1] - The company is focused on promoting the development of high-end application areas [1]

Core Viewpoint - The company is closely monitoring the application dynamics of polyethylene glycol across various fields, indicating a proactive approach to market trends and potential growth areas [1] Group 1: Company Developments - The company has confirmed that its products have achieved large-scale applications in the pharmaceutical raw materials, lithium battery new energy, and daily chemical sectors [1]

Group 1 - The company, Aoke Co., Ltd. (300082), stated on October 14 that it produces and sells battery-grade polyethylene glycol, which has good quality and is in a leading position within the industry [1]

Core Viewpoint - The stock of Aok Chemical Co., Ltd. has experienced fluctuations, with a current price of 7.98 CNY per share, reflecting a year-to-date increase of 27.27% and a recent decline over the past 20 days [1][2]. Financial Performance - For the first half of 2025, Aok Chemical achieved a revenue of 2.042 billion CNY, representing a year-on-year growth of 11.21%. The net profit attributable to shareholders was 1.3035 million CNY, showing a significant increase of 101.29% [2]. - The company has cumulatively distributed 1.453 billion CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]. Stock Market Activity - As of October 14, Aok Chemical's stock saw a trading volume of 55.99 million CNY, with a turnover rate of 1.02%. The stock has been on the龙虎榜 (top trading list) once this year, with a net buy of 86.67 million CNY on June 5 [1]. - The stock has seen a net outflow of 4.87 million CNY from major funds, with significant buying and selling activity from large orders [1]. Company Overview - Aok Chemical, established on January 1, 2000, and listed on May 20, 2010, specializes in the research, production, and sales of ethylene-derived green low-carbon fine chemicals and advanced new materials [1]. - The company's main revenue sources include polyether monomers (65.11%), polyethylene glycol (20.58%), and fatty alcohol ethers (13.99%) [1].

Group 1 - The company, Aoke Co., Ltd. (300082.SZ), is recognized for producing and selling battery-grade polyethylene glycol, which is noted for its high quality and leading position in the industry [2]. - An investor inquired about the company's total sales in the context of the lithium battery polyether materials sector, indicating a competitive landscape [2]. - The company confirmed that its sales of polyethylene glycol are the highest globally, highlighting its strong market presence [2].

Core Viewpoint - The company, Aoke Co., Ltd. (stock code: 300082), has indicated that its polyethylene glycol (PEG) products are primarily used in pharmaceutical excipients, active pharmaceutical ingredients, lithium battery new energy, and daily chemicals, with ongoing research and development for PEO materials [1] Group 1 - The company's PEG products are mainly applied in the pharmaceutical and chemical industries [1] - Ongoing research and development efforts are focused on PEO materials [1] - The company will disclose any necessary information in compliance with legal requirements [1]

Core Viewpoint - The company maintains a relatively stable capital structure and strong financing capabilities in the capital market, with a high shareholding ratio from the controlling shareholder [1] Group 1 - The company plans to dynamically adjust the scale, content, and actual investment amount of its projects based on market demand and technical solutions [1] - The company will carefully evaluate and continuously optimize its financing strategy [1] - The company is committed to enhancing its core competitiveness and profitability in its main business [1]

Group 1 - The company is closely monitoring the application dynamics of polyethylene glycol (PEG) across various fields [2] - Currently, the company's PEG is primarily used in pharmaceutical excipients, active pharmaceutical ingredients, lithium battery new energy, and daily chemicals [2]